Biotech · Private company

Sarah Cannon

Track this companyFree. Adds Sarah Cannon to your Dealase workspace and tells you when its record changes.

Clinical trials41 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials4

Sequential Therapy in Multiple Myeloma Guided by MRD AssessmentsPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 13, 2023ClinicalTrials.gov NCT05231629 · fetched Nov 12, 2026
A Study of Enzalutamide and LY3023414 in Men With Prostate CancerPHASE2 · COMPLETED · started Apr 29, 2015ClinicalTrials.gov NCT02407054 · fetched Nov 12, 2026
A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer PatientsPHASE3 · TERMINATED · started Feb 25, 2014ClinicalTrials.gov NCT01905592 · fetched Nov 12, 2026
A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerPHASE3 · COMPLETED · started Jun 21, 2013ClinicalTrials.gov NCT01847274 · fetched Nov 12, 2026